国际医药卫生导报2012，Vol.18Issue(11)：1589-1590,2.DOI:10.3760/cma.j.issn.1007-1245.2012.11.019
子宫内膜异位症术后应用曲普瑞林和米非司酮治疗的疗效观察
The efficacy of triptorelin or mifepristone for endometriosis after surgery
摘要
Abstract
Objective To explore the clinical efficacy of triptorelin or mifepristone for endometriosis after surgery.Methods 120 patients with endometriosis who had been hospitalized during the period of August 2007 to October 2011 were randomly assigned to receive triptorelin ( 40 patients,group A ),mifepristone ( 40 patients,group B ),or conventional therapy ( 40 patients,group C ) for six months after surgery.The efficacy was observed.Results Dysmenorrhea and menorrhagia were relieved at different degrees in groups A and B.The effectiveness rate was 97.5％ in group A and 95％ in group B,which was higher than that in group C ( 75％ ).The rate of abnormal vaginal hemorrhage was significantly lower in group A ( 5％ ) than in group B ( 22.5％ ) and group C ( 45％ ),with a significant difference ( P＜0.05 ).Conclusions Surgery is the major therapy for endometriosis.Postoperative uses of triptorelin or mifepristone can evidently improve symptoms of the disorder.Triptorelin can be used as th medication of first choice for consolidation treatment due to better efficacy and fewer adverse reactions.关键词
子宫内膜异位症/曲普瑞林/临床价值Key words
Endometriosis/Triptorelin/Efficacy引用本文复制引用
叶文贤..子宫内膜异位症术后应用曲普瑞林和米非司酮治疗的疗效观察[J].国际医药卫生导报,2012,18(11):1589-1590,2.
